Formation of delivery agents targeted to degraded elastic fibers

• US 10,688,061 B2
• Filed: 02/01/2017
• Issued: 06/23/2020
• Est. Priority Date: 06/28/2012
• Status: Active Grant

• Current Assignee: Clemson University
• Original Assignee: Clemson University
• Inventors: Vyavahare, Naren, Sinha, Aditi
• Primary Examiner(s): Kim, Yunsoo
• Application Number:
  US15/421,604
• Publication Number:
  US 20170209592A1
• Time in Patent Office: 1,238 Days
• Field of Search: None
• CPC Class Codes: A61K 39/44 Antibodies bound to carriers
• CPC Class Codes: A61K 47/02 Inorganic compounds
• CPC Class Codes: A61K 47/6843 the antibody targeting a material from animals or humans
• CPC Class Codes: A61K 47/6937 the polymer being PLGA, PLA or polyglycolic acid
• CPC Class Codes: A61K 9/5146 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
• CPC Class Codes: A61K 9/5153 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: C07K 16/18 against material from animals or humans
• CPC Class Codes: C07K 16/2836 against CD106

Abstract

Methods and delivery agents for treatment of connective tissue that includes elastic fibers are described. Delivery agents are nano- or micro-sized particles that include a biologically active compound useful in treatment of degraded elastic fibers and an anchoring agent at a surface that binds at or near the area of degraded elastic fibers. The delivery agents may be utilized for targeted delivery of biologically active compounds to degraded elastic fibers so as to maintain and/or regenerate the elastin component of connective tissue, and prevent further degradation and/or rehabilitate the structural architecture of the connective tissue.

Claims

1. A method of forming a delivery agent, the method comprising:

forming a micro- or nano-sized biodegradable particle, the biodegradable particle comprising a biocompatible polymer;

associating a biologically active agent with the particle, the biologically active agent comprising a tannin, a flavonoid, a flavolignan, a phenolic rhizome, a favan-3-ol a cathepsins inhibitor, an MMP inhibitor, an elastase inhibitor, a lysyl oxidase, copper ions, forskolin, TGF-β

, ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid, Nitrilotriacetic acid, hydroxyethyl ethylenediaminetriacetic acid, 8-Hydroxy-7-iodo-5-quinolinesulfonic acid, poly(gamma-glutamic acid, sodium thiosulphate, or alpha-lipoic acid; and

attaching an anchoring agent to a surface of the biodegradable particle, the anchoring agent comprising an anti-elastin antibody or a fragment thereof that specifically binds amorphous cross-linked elastin.

2. The method of claim 1, the step of forming the micro- or nano-sized biodegradable particle comprising crosslinking the polymer.

3. The method of claim 2, wherein the polymer is a biological polymer.

4. The method of claim 2, the step of forming the micro- or nano-sized biodegradable particle comprising precipitating the particle from a solution comprising the polymer.

5. The method of claim 4, the step of associating the biologically active agent with the particle comprising carrying out the precipitation of the particle in the presence of the biologically active agent.

6. The method of claim 1, further comprising developing a negative surface charge on the surface of the particle.

7. The method of claim 1, the step of associating the biologically active agent with the particle comprising swelling the particle in the presence of the biologically active agent.

8. The method of claim 1, the step of associating the biologically active agent with the particle comprising binding the biologically active agent to a component of the particle.

9. The method of claim 8, wherein the biologically active agent is bound to the surface of the particle.

10. The method of claim 8, wherein the biologically active agent is non-covalently bound to the component of the particle.

11. The method of claim 1, the method further comprising raising the anti-elastin antibody against amorphous cross-linked elastin or a fragment of amorphous cross-linked elastin.

12. The method of claim 11, the step of raising the anti-elastin antibody comprising immunizing a host with the amorphous cross-linked elastin or the fragment of amorphous cross-linked elastin and harvesting antiserum from the host when antibody titer begins to fall.

13. The method of claim 11, the step of raising the anti- elastin antibody comprising immunizing a host with the amorphous cross-linked elastin or the fragment of amorphous cross-linked elastin and preparing hybridoma cells from spleen cells of the immunized host.

14. The method of claim 1, the method of attaching the anchoring agent to the surface of the biodegradable particle comprising thiolating the anti-elastin antibody.

15. The method of claim 1, the step of attaching the anchoring agent to the surface of the biodegradable particle comprising covalently bonding the anchoring agent to a reactive group at the surface of the particle.

16. The method of claim 1, the step of attaching the anchoring agent to the surface of the particle comprising adsorbing the anchoring agent to the surface.

17. The method of claim 1, further comprising tethering a molecular spacer between the anchoring agent and the surface of the particle.

18. The method of claim 1, the biocompatible polymer comprising a homopolymer or copolymer comprising polysaccharide, a poly(lactic acid), or a poly(ethylene glycol).

19. The method of claim 18, the biocompatible polymer comprising a copolymer comprising poly(lactic acid) and poly(ethylene glycol).

20. the method of claim 1, the biologically active agent comprising a tannin.

21. The method of claim 20, the biologically active agent comprising pentagalloylglucose.